Live from the NIH registry
Studies recruiting near Port St. Lucie right now
Top 25 of 104 recruiting studies, sorted by proximity — each links to its official registry page
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer
Phase 3
Interventional 590 participants sought
Cleveland Clinic Martin North — Stuart, Florida (10.1 mi)
· Sponsor: Revolution Medicines, Inc.
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
N/A
Interventional 290 participants sought
CDC Research Institute — Port Saint Lucie, Florida (2.5 mi)
· Sponsor: Philip Morris Products S.A.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
Jupiter Medical Center — Jupiter, Florida (29.9 mi)
· Sponsor: NRG Oncology
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Health Awareness — Jupiter, Florida (29.9 mi)
· Sponsor: Eli Lilly and Company
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF)
Phase 3
Interventional 460 participants sought
The Anderson Family Cancer Institute — Jupiter, Florida (29.9 mi)
· Sponsor: Novartis Pharmaceuticals
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
HIV Infections
Phase 3
Interventional 590 participants sought
Midway Immunology and Research Center — Ft. Pierce, Florida (12.2 mi)
· Sponsor: Gilead Sciences
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
Metabolic Dysfunction-associated Steatohepatitis
Phase 2
Interventional 160 participants sought
Health Awareness, Inc. — Jupiter, Florida (29.9 mi)
· Sponsor: Eccogene
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Leukemia, Myeloid, Acute
Phase 3
Interventional 600 participants sought
Jupiter Research — Jupiter, Florida (29.9 mi)
· Sponsor: Janssen Research & Development, LLC
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Endometrial Cancer, Malignant Solid Tumour
Phase 3
Interventional 800 participants sought
Research Site — Jupiter, Florida (29.9 mi)
· Sponsor: AstraZeneca
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Relapsing Multiple Sclerosis
Phase 3
Interventional 400 participants sought
Vero Beach Neurology — Vero Beach, Florida (24.8 mi)
· Sponsor: Novartis Pharmaceuticals
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Alzheimers Disease
Phase 3
Interventional 800 participants sought
Alzheimer's Research and Treatment Center — Stuart, Florida (10.1 mi)
· Sponsor: Hoffmann-La Roche
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
High Risk Cardiovascular Disease, Hypertension
Phase 3
Interventional 11,000 participants sought
Clinical Trial Site — Jensen Beach, Florida (9.9 mi)
· Sponsor: Alnylam Pharmaceuticals
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Metastatic Colorectal Cancer (CRC)
Phase 3
Interventional 600 participants sought
Clinical Study Site — Port Saint Lucie, Florida (2.5 mi)
· Sponsor: Summit Therapeutics
Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity
Primary Sjögren's Syndrome
Phase 2
Interventional 180 participants sought
Site Number - 1021 — Jupiter, Florida (29.9 mi)
· Sponsor: Immunovant Sciences GmbH
Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 Treatment
HIV-1-infection
Phase 2, Phase 3
Interventional 700 participants sought
Midway Immunology and Research Center — Ft. Pierce, Florida (12.2 mi)
· Sponsor: Gilead Sciences
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
Pain
N/A
Observational 4,800 participants sought
Louis J. Raso, MD, PA — Jupiter, Florida (29.9 mi)
· Sponsor: Boston Scientific Corporation
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Phase 3
Interventional 1,350 participants sought
89bio Clinical Study Site — Jupiter, Florida (29.9 mi)
· Sponsor: 89bio, Inc.
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 3
Interventional 360 participants sought
Jupiter Medical Center — Jupiter, Florida (29.9 mi)
· Sponsor: National Cancer Institute (NCI)
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Cleveland Clinic Martin North Hospital ( Site 0114) — Stuart, Florida (10.1 mi)
· Sponsor: Merck Sharp & Dohme LLC
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Phase 3
Interventional 466 participants sought
Jupiter Medical Center — Jupiter, Florida (29.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Prospective Study to Assess a Diagnostic Aid for Cancer
Cancer
N/A
Observational 2,450 participants sought
Stuart Oncology Associates — Stuart, Florida (10.1 mi)
· Sponsor: Harbinger Health
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 189 participants sought
Jupiter Medical Center — Jupiter, Florida (29.9 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 734 participants sought
Health Awareness, Inc. - Port St. Lucie — Port Saint Lucie, Florida (2.5 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Galderma Investigational Site 7101 — Jupiter, Florida (29.9 mi)
· Sponsor: Galderma R&D
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
HR+/HER2- Breast Cancer
Phase 3
Interventional 1,056 participants sought
Hematology Oncology Associates of the Treasure Coast — Port Saint Lucie, Florida (2.5 mi)
· Sponsor: BeOne Medicines